Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society Unaudited Financial Statements Year Ended 31 March 2025
Company Registration Number 06996552 Charity Registration Number 1136972
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Financial Statements
Year Ended 31 March 2025
| Contents | Page |
|---|---|
| Trustees' Report | 1 |
| Independent Examiner’s Report | 4 |
| Statement of Financial Activities | 5 |
| Balance Sheet | 6 |
| Notes to the Financial Statements | 7 |
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Trustees’ Report (continued)
Year Ended 31 March 2025
The trustees have pleasure in presenting their report and the unaudited financial statements of the charitable company for the year ended 31 March 2025.
Status
The charitable company is limited by guarantee, having no share capital. Under the provisions of Section 60 of the Companies Act 2006, the company is entitled to omit the word "Limited" from its name. The governing document of the charitable company is its Memorandum and Articles of Association.
The charitable company is also known as UKONS.
Objects and Activities of the Charity
The objects of the charitable company are, for the public benefit:
-
To advance health and to relieve those in need by reason of ill-health, including without limitation people affected by cancer; and
-
To advance the education of the public in the subjects of health, medical and nursing care, including without limitation the causes, effects and treatments of cancer.
Aims of the charity
-
To promote excellence in the nursing care and management of all those directly and indirectly affected by cancer.
-
To encourage and facilitate the personal and professional development of nurses engaged in cancer care throughout the UK and overseas through education, research and policy.
-
To share information about research, learning and development opportunities with UKONS members.
-
To contribute to the development of cancer policy, clinical practice and service delivery nationally and internationally.
-
To foster alliances and develop UK and international networking opportunities.
Activities and achievements aligned to the charity’s aims for the year 2024/25
-
Continuation of the Members Interest Groups: Personalised Cancer Care; Acute Oncology Services; Systemic Anti-cancer Treatments; Radiotherapy; Haemato-oncology; Lead Cancer Nurses; Research
-
A further Members Interest Group- ‘Young and Early Career Cancer Nurses’ was added in 2021 and fully established as an interest group with annual webinar activity and a Facebook and social media presence.
-
UKONS as part of the SACT interest group has implemented a practice educator forum.
-
Continuation of our provision of the UKONS website (www.ukons.org), catering to the needs of members and the members interest groups.
-
Continued publication of fortnightly editions of UKONS ‘Breaking News’ bulletin, supporting ‘top stories’ from practice, workforce surveys, academic and study day opportunities. This aids practice development and career progression. Breaking news is sent to all member via e-mail. Breaking news also includes cancer nurse job advertisements, which are offered free of charge.
-
In 24/25 the collaboration for Breaking News continues to be delivered jointly between UKONS and Macmillan Cancer Support. This collaboration is underpinned by an MOU agreement and signed by both parties, renewed in 2024.
-
As the main output from UKONS the in person annual conference continues to gain internet in both abstract submissions and attendance. Last year’s themes was Working towards positive change in cancer care", which was held at the Manchester Conference Centre on November 14–15, 2024. This provided the opportunity for cancer nurses to present orally, and through posters on education,
3
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Trustees’ Report (continued)
Year Ended 31 March 2025
innovation and research. The conference programme and abstracts were held in a handheld application for ease before and during the conference. Last year we aimed to increase the number of sessions where chose abstracts presented in breakout sessions and the plenary sessions.
SACT Members Interest Group:
-
After the launch of the SACT passport in January 2024 , this mobile application is currently being implemented and embed into practice with a distribution across the four nations of the UK. The reach includes Southern Ireland. This mobile application is being embedded both in NHS trust and academic institutions. The collaboration continues with the competency passport application ‘ Compassly’ and Tefogo Ltd.
-
During 2024/25 UKONS continued to be a prominent member of the UK SACT Board (formally UK Chemotherapy Board) delivering guidelines across all four nations for the delivery of systemic anticancer therapies.
-
The SACT MIG also delivered three webinars across the year.
-
Noted a change in SACT link board
-
Hypersensitivity Guidelines developed.
Acute Oncology Members Interest Group:
-
Continued to approve translations of the UKONS Acute Oncology Triage Tool as well as working formalise and deliver electronic versions of the tool.
-
The eLearning course in partnership with E learning for Health NHS England. Is being requested for access internationally (Malta and Florida).
-
UKONS launched with the UK Acute Oncology Society and Macmillan to standardise AO education, training and assessment and advanced work on multi-professional AO competency passports.
-
The AOS MIG delivered one webinar with 400 delegates.
-
Presented at AOS Ireland conference
-
Presented at Oncology Forum Conference.
Personalised Cancer Care Members Interest Group:
-
This Mig continues to evolve and define the focus
-
Held one webinar 24/25
-
Personalised Cancer Care book is in progress.
Radiotherapy Members Interest Group :
- Held a webinar and first breakout session at the annual conference.
Haematology Members Interest Group:
-
Has delivered three webinars in collaboration with partners and charity organisations.
-
Held first break out session at the annual conference.
-
Has held a well-attended session at the British haematology Society conference in Glasgow.
-
Continues to seek partnerships for education and research Grants.
-
Online Survey for learning needs
-
Involved in a systematic review for Seminar in Oncology Nursing
Research Members Interest Group:
-
Research is now present in all Migs
-
Research continues to review research and survey requests.
4
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Trustees’ Report (continued)
Year Ended 31 March 2025
Education Competency and Capability:
-
UKONS continued to be a central organisation in promoting the ACCEND (Aspirant Cancer Career and Education Development) programme. This career framework provides guidance and structure or all health care professionals wishing to develop a career in cancer care.
-
Organised and presented education, training sessions and symposia at virtual and face-to-face events for both UKONS and other organisations throughout the year, including the UK Oncology Forum and the Oncology Professional Care Conference, British Hematology Society. International Cancer Nursing Society and the European Oncology Nursing Society.
-
Work commenced and continued on a book on the impact of the COVID pandemic in cancer care across Europe in partnership with Springer Press.
Growing forums:
Work continues to take requests from members for forum activity:
Practice Educator Forum:
-
Ongoing 4-6 weekly forums online
-
Webinar x1
Champions Forum:
-
Cancer and domestic Abuse Kit
-
Breaking News
-
Supporting conference Stands
-
Assist in chairing the conference sessions
Lead Nurse Forum:
-
In-person meeting
-
Two online (half day)
-
Membership continues to increase with good peer support & networking
-
• Closed Facebook page
Young and Early Career Forum (YECC):
-
Co-opted board members
-
Annual online webinar
Partnership working: .
-
Continued to work with a wide range of industry partners and develop further relationships, extending our numbers of partners to more than 20.
-
Collaborated with: NHS England, UK Oncology Forum; British Journal of Nursing; Cancer Nursing Practice, The European Oncology Nursing Society (EONS); International Society of Nurses in Cancer Care (ISNCC); Royal Collage of Nursing.
-
Representation at the UK Chemotherapy Board; various NHS Working Groups (including those on SACT Capacity and Workforce); Macmillan Cancer Support/HEE.
-
Provision of basic oncology education continues to be provided by O’Hallaran Consultancy, to all UKONS members.
-
Collaboration with Macmillan Cancer Support to provide Podcasting on topical issues available through podcasting platforms and accessible worldwide.
5
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Trustees’ Report (continued)
Year Ended 31 March 2025
Organisational Structure
The Board has five executive officers: President, President Elect, Past President, Secretary and Treasurer. It has an additional ten full Board members who are all Trustees. New Trustees receive induction into their role on the Board.
Assessment of going concern
The charity’s income is reliant on sponsorship from UKONS Partners. Income for 24/25 was reduced from the previous year but not significantly. It continues to be unpredictable for some partners and their budget constraints. The board maintain a cautious approach and these factors have been considered in budgeting resources for the next financial year.
Directors and Trustees
The directors and trustees who served the company during the year and up to the date of this report were as follows:
Karen Campbell (President) Mary Tanay (President Elect) Mark Foulkes (Past President) Lyndel Moore (Treasurer) Jo Bird (Secretary - appointed 4 December 2024) Kay Bell (resigned 4 December 2024) Rachel Bryce (appointed 4 December 2024) Naomi Clatworthy Jane Ewang (appointed 4 December 2024) Ruth Hammond Nicola Jones (appointed 4 December 2024) Nalayini Kumaralingam (resigned 5 December 2024) Bethany Maynard (appointed 4 December 2024) Barry Quinn Rosemary Roberts (resigned 4 December 2024) Constance Rowell Linda Sherwood Tracy Wilson Debbie Wightman (resigned 4 December 2024)
Reserves
The Trustees plan to retain a modest level of reserves as a contingency fund against future demands on the charity’s resources.
Small Company Provisions
This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.
Signed on behalf of the directors [aren …………………………… BA8F1726C53B49B...by: Dr Karen Campbell Director
03 September 2025 Approved on ……………………………………2025
6
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Independent Examiner’s Report to the Trustees
Year Ended 31 March 2025
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2025.
Responsibilities and basis of report
As the charity’s trustees (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent examiner’s statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
[fartSigned342D60FB7F7A405...by: Kobbs
Martin Hobbs BSc ACA
Francis Clark LLP Chartered Accountants Sigma House Oak View Close Edginswell Park Torquay TQ2 7FF
04 September 2025 Date: ……………………………..2025
7
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Statement of Financial Activities (incorporating an Income and Expenditure Account)
Year Ended 31 March 2025
| Unrestricted | Restricted | Total | Total | |
|---|---|---|---|---|
| Funds | Funds | 2025 | 2024 | |
| £ | £ | £ | £ | |
| Income from: | ||||
| Partnership income | 130,500 | - | 130,500 | 147,042 |
| Board activity | 5,885 | - | 5,885 | 19,235 |
| Donations | - | - | - | 1,408 |
| Grants | - | - | - | 40,000 |
| Other income | - | - | - | 16,667 |
| ––––—— | ––––—— | ––––—— | ––––—— | |
| Total | 136,385 | - | 136,385 | 224,352 |
| ––––—— | ––––—— | ––––—— | ––––—— | |
| Expenditure on: | ||||
| BJN Awards | 27 | - | 27 | 277 |
| CASCADE workshop | - | - | - | 2,111 |
| Covid 19 and Cancer book | - | - | - | 11,402 |
| Personalised Cancer Care Book | - | - | - | 4,000 |
| Pocketbook of Cancer Care Nursing | - | - | - | 8,333 |
| Cytotoxic Drug Exposure Research Grant | 13,348 | - | 13,348 | - |
| SACT passport project | 16,244 | 16,244 | 58,435 | |
| EBN Health book | - | - | - | 2,917 |
| Palliative care booklet | - | - | - | - |
| EONS membership fee | 835 | - | 835 | 875 |
| ISNCC membership fee | 494 |
- | 494 | 248 |
| Annual conference | 19,112 | - | 19,112 | 38,122 |
| Board meetings – Travel and subsistence | 6,464 | - | 6,464 | 7,784 |
| Other conferences | 927 | - | 927 | 14,634 |
| Entertaining/other meetings | 2,116 | - | 2,116 | 14,346 |
| MIGs | 5,509 | - | 5,509 | 8,202 |
| Administrative support | 21,600 | - | 21,600 | 26,760 |
| Secretarial services | 15,000 | - | 15,000 | 15,000 |
| Legal and professional | 795 | - | 795 | 660 |
| Stationery and admin | - | - | - | 186 |
| Website and social media | 8,091 | - | 8,091 | 7,043 |
| Accounting fees | 10,744 | - | 10,744 | 10,320 |
| Insurance | 1,068 | - | 1,068 | 985 |
| Irrecoverable VAT | 8,174 | - | 8,174 | 10,997 |
| Grants BMS AOS | 484 | - | 484 | 36,485 |
| Purchases | 325 | - | 325 | 10,734 |
| ––––—— | ––––—— | ––––—— | ––––—— | |
| Total | 131,357 | - | 131,357 | 290,856 |
| ––––—— | ––––—— | ––––—— | ––––—— | |
| Net income/(expenditure) | 5,028 | - | 5,028 | (66,504) |
| Total funds brought forward | 122,303 | - | 122,303 | 188,807 |
| ––––—— | ––––—— | ––––—— | ––––—— | |
| Total funds carried forward | 127,331 | - | 127,331 | 122,303 |
| ══════ | ══════ | ══════ | ══════ |
All of the incoming resources of the charity for the comparative year are unrestricted. All of the above results are derived from continuing activities. All gains and losses recognised in the year are included above. The result for the year for Companies Act purposes is equivalent to the net income / (expenditure).
8
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Balance Sheet
31 March 2025
| Notes | 2025 | 2024 | |
|---|---|---|---|
| £ | £ | ||
| Current assets | |||
| Debtors | 4 | 55,827 | 53,095 |
| Cash at bank and in hand | 189,265 | 151,808 | |
| ––––—— | ––––—— | ||
| 245,092 | 204,903 | ||
| Liabilities | |||
| Creditors falling due within one year | 5 | (117,761) | (82,600) |
| ––––—— | ––––—— | ||
| Total assets less current liabilities | 127,331 | 122,303 | |
| ══════ | ══════ | ||
| Unrestricted funds | 6 | 127,331 | 122,303 |
| Restricted funds | 6 | - | - |
| ––––—— | ––––—— | ||
| Total funds | 127,331 | 122,303 | |
| ══════ | ══════ |
The directors are satisfied that the company is entitled to exemption from the provisions of the Companies Act 2006 (the Act) relating to the audit of the financial statements for the year by virtue of section 477, and that no member or members have requested an audit pursuant to section 476 of the Act.
The directors acknowledge their responsibilities for:
-
(i) ensuring that the company keeps adequate accounting records which comply with section 386 of the Act, and
-
(ii) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit or loss for the financial year in accordance with the requirements of sections 394 and 395, and which otherwise comply with the requirements of the Act relating to financial statements, so far as is applicable to the company.
These financial statements have been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act.
These financial statements were approved and signed by the trustees and authorised for issue on …………………………. 2025, and are signed on their behalf by: 03 September 2025
[aren ……………………………….. BA8F1726C53B49B...by: Karen Campbell
Director
Company Registration Number: 06996552
9
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Notes to the Financial Statements
Year Ended 31 March 2025
1 Accounting Policies
Basis of accounting
The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:
a) Basis of preparation of financial statements and assessment of going concern
The financial statements have been prepared under the historical cost convention and in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) – (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
The UK Oncology Nursing Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The functional and presentational currency of these financial statements is sterling.
The trustees consider that there are no material uncertainties about the Charity’s ability to continue as a going concern.
b) Income
Income is recognised when the charity has entitlement to funds, any performance conditions attached to the items of income have been met, it is probable that the income will be received and the amount can be measured reliably.
Capital grants receivable are credited to the SOFA as they become receivable and are treated as restricted funds. The depreciation on the assets to which the grants relate is charged against these funds.
c) Fund accounting
Unrestricted funds are funds available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Restricted funds are funds received which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes.
d) Expenditure
Expenditure is recognised once there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure includes irrecoverable VAT.
e) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. The company holds the following financial instruments, all of which are considered to be basic:
-
Short term debtors and creditors
-
Cash and bank balances
10
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Notes to the Financial Statements
Year Ended 31 March 2025
2 Related Party Transactions
During the year travel expenses of £3,270 were reimbursed to 12 trustees (2024: £11,919 to 13 trustees).
3 Company Limited by Guarantee
The company is limited by guarantee and has no share capital. In the event of a winding-up, the liability of the members is limited to £1 each. The Charity is incorporated in England and Wales. The address of its registered office is: Office 605, Albert House, 256-260 Old St, London EC1V 9DD.
4 Debtors
| Creditors: amounts falling due within one year Trade debtors Prepayments and accrued income VAT Accruals and deferred income VAT payable Other creditors |
2025 £ 2024 £ 49,294 40,702 6,533 5,599 - 6,794 55,827 53,095 2025 £ 2024 £ 106,905 82,600 10,856 - - - |
|---|---|
| 117,761 82,600 |
5 Creditors: amounts falling due within one year
6 Analysis of movement in funds
| Total unrestricted funds | Balance at 1 April 2024 £ Incoming resources £ Resources expended £ Balance at 31 March 2025 £ 122,303 136,385 (131,357) 127,331 |
|---|---|
| 122,303 136,385 (131,357) 127,331 |
11
Docusign Envelope ID: 49C915B9-A422-480E-9C73-691226D84312
The UK Oncology Nursing Society
Notes to the Financial Statements
Year Ended 31 March 2025
6 Analysis of movement in funds (continued)
Prior year analysis of movement in funds
| Total unrestricted funds Restricted funds: Gilead BMS AOS education grant EBN book grant |
Balance at 1 April 2023 £ Incoming resources £ Resources expended £ Balance at 31 March 2024 £ 183,660 184,352 (245,709) 122,303 - 5,000 (5,000) - - 35,000 (35,000) - 2,230 - (2,230) - 2,917 - (2,917) - |
|---|---|
| 188,807 224,352 (290,856) 122,303 |
The Gilead grant represents funds to support healthcare professionals to attend the UKONS 2023 conference.
The BMS AOS grant represents funds raised towards the development of acute oncology service telephone triage E-learning modules
The AOS education grant represents funds raised for the development of a digital friendly format for UKONS guidance for assessment of patients.
The EBN book grant represents funds raised for the writing and publication of a reference book entitled “Fundamentals of Cancer Care”.
The restricted funds are all held as cash at bank and in hand.
12